Why the study?
Surgical treatment of renal cell carcinoma with an extended inferior vena cava tumour thrombus is challenging, prompting analysis of real-world management, perioperative complications, and oncologic outcomes.
What are the perioperative and oncologic outcomes of radical nephrectomy with tumour thrombectomy in patients with RCC and extended IVC tumour thrombus?
What are the perioperative and oncologic outcomes of radical nephrectomy with tumour thrombectomy in patients with RCC and extended IVC tumour thrombus?
Radical nephrectomy with tumour thrombectomy is a feasible and effective treatment for RCC with extended IVC tumour thrombus, with primary metastatic disease being the main predictor of overall survival.
Primary metastasis predicts OS after thrombectomy; leaves open surgical benefit in non-metastatic extended IVC thrombus.
PURPOSE: Surgical treatment of patients with renal cell carcinoma (RCC) and an extended tumour thrombus (TT) in the inferior vena cava (IVC) is challenging and often requires a multidisciplinary approach. The aim of this study was to analyse results in the real-world management of RCC patients with an extended IVC TT (level II-IV according to the Mayo classification of macroscopic venous invasion in RCC) in terms of pre-, peri- and postoperative outcome, complications and oncologic outcome. METHODS: We investigated 61 patients with evidence of RCC and an extended TT in the IVC undergoing radical nephrectomy and tumour thrombectomy at our tertiary referral centre. Patients and operative characteristics were recorded and complications were analysed using the Clavien-Dindo classification. Follow-up data were retrieved by contacting the treating outpatient urologists, general practitioners and patients. RESULTS: The TT level was II in 36, III in 8 and IV in 17 patients. Complications grade IIIb and higher according to the Clavien-Dindo classification occurred in n = 3 (8.4 %), n = 2 (25.0 %) and n = 5 (29.5 %) patients with level II, III and IV TT, respectively. The overall survival of patients with TT level II, III and IV at 24 months (60 months) was 66.9 % (41.6 %), 83.3 % (83.3 %) and 64.1 % (51.3 %). Presence of primary metastatic disease was the only significant independent predictor for OS. CONCLUSIONS: Radical nephrectomy with tumour thrombectomy appears to be a feasible and effective treatment option in the management of patients with RCC and an extended IVC TT.
No takes yet. Share an insight, caveat, or question.
Adams et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: